HIV stigma limits the effectiveness of PMTCT in Guinea: the ANRS 12344-DIAVINA study von Breton, Guillaume, Diallo, Oumou Hawa, Cissé, Mohamed, Diallo, Oumou Hawa, Diallo, Néné Aissatou, Soumaoro, Sény Agnès, Camara, Yalikhatou, Montoyo, Alice, Rouzioux, Christine, Koita, Youssouf, Peytavin, Gilles, Tubiana, Roland, Frange, Pierre

Volltext

882TiP InnovaTV 208: New weekly dosing cohort in the phase II study of tisotumab vedotin in platinum-resistant ovarian cancer von Blank, S., Mahdi, H., Tehrani, O., Ghamande, S., Jain, S., Nicacio, L., Soumaoro, I., O'Malley, D.M.

Volltext

930TiP innovaTV 207: New dosing cohort in the open label phase II study of tisotumab vedotin in solid tumors von Hong, D., Fayette, J., Birnbaum, A., Steuer, C., Taylor, M.H., George, T.J., Lacy, J., Beca, F., Nicacio, L.V., Soumaoro, I., Cho, M.

Volltext

1064TiP - Phase I/II trial of tisotumab vedotin plus bevacizumab, pembrolizumab, or carboplatin in recurrent or metastatic cervical cancer (innovaTV 205/ENGOT-cx8) von Vergote, I.B., Concin, N., Mirza, M.R., Malmberg, A., Eaton, L., Nicacio, L., Lorusso, D., Soumaoro, I., Monk, B.J., O’Malley, D.M.

Volltext

Phase I/II trial of tisotumab vedotin plus bevacizumab, pembrolizumab, or carboplatin in recurrent or metastatic cervical cancer (innovaTV 205/ENGOT-cx8) von Vergote, I.B., Concin, N., Mirza, M.R., Malmberg, A., Eaton, L., Nicacio, L., Lorusso, D., Soumaoro, I., Monk, B.J., O’Malley, D.M.

Volltext

288MO InnovaTV 301/ENGOT-cx12/GOG-3057: A global, randomized, open-label, phase III study of tisotumab vedotin vs investigator’s choice of chemotherapy in 2L or 3L recurrent or met... von Fujiwara, K., Slomovitz, B.M., Gonzalez Martin, A., Kalbacher, E., Bagameri, A., Ghamande, S., Lee, J-Y., Banerjee, S., Maluf, F.C., Lorusso, D., Yonemori, K., van Nieuwenhuysen, E., Manso Sanchez, L.M., Woelber, L., Westermann, A.M., Covens, A., Whalley, E., Teng, M.S.L., Soumaoro, I., Vergote, I.B.

Volltext

LBA9 innovaTV 301/ENGOT-cx12/GOG-3057: A global, randomized, open-label, phase III study of tisotumab vedotin vs investigator’s choice of chemotherapy in 2L or 3L recurrent or meta... von Vergote, I.B., Gonzalez Martin, A., Fujiwara, K., Kalbacher, E., Bagameri, A., Ghamande, S., Lee, J-Y., Banerjee, S., Maluf, F.C., Lorusso, D., Yonemori, K., Van Nieuwenhuysen, E., Manso Sanchez, L.M., Woelber, L., Westermann, A.M., Covens, A., Whalley, E., Teng, M.S.L., Soumaoro, I., Slomovitz, B.M.

Volltext

1064TiPPhase I/II trial of tisotumab vedotin plus bevacizumab, pembrolizumab, or carboplatin in recurrent or metastatic cervical cancer (innovaTV 205/ENGOT-cx8) von Vergote, I B, Concin, N, Mirza, M R, Malmberg, A, Eaton, L, Nicacio, L, Lorusso, D, Soumaoro, I, Monk, B J, O’Malley, D M

Volltext

723MO Tisotumab vedotin (TV) + carboplatin (Carbo) in first-line (1L) or + pembrolizumab (Pembro) in previously treated (2L/3L) recurrent or metastatic cervical cancer (r/mCC): Int... von Vergote, I.B., Monk, B.J., O’Cearbhaill, R.E., Westermann, A.M., Banerjee, S., Collins, D.C., Mirza, M.R., O'Malley, D., Gennigens, C., Pignata, S., Melichar, B., Sadozye, A., Forget, F., Tewari, K.S., Gort, E., Soumaoro, I., Mondrup Andreassen, C., Nicacio, L.V., Van Nieuwenhuysen, E., Lorusso, D.

Volltext

5P Tisotumab vedotin (TV) dose schedule optimization in non-cervical populations von Voellinger, J., Passey, C., Feng, Y.S., Gunawan, R., Gibiansky, L., Polhamus, D., Gerritsen, A., O'Day, C., Nicacio, L., Soumaoro, I., Gupta, M., Hanley, W.

Volltext

An open-label, multicohort, phase 1/2 study in patients with virus-associated cancers (CheckMate 358): Safety and efficacy of neoadjuvant nivolumab in squamous cell carcinoma of th... von Ferris, R.L., Gonçalves, A., Baxi, S.S., Martens, U.M., Gauthier, H., Langenberg, M., Spanos, W.C., Leidner, R.S., Kang, H., Russell, J., Chiosea, S., Soumaoro, I., Rao, S., Cao, Z.A., Topalian, S.

Volltext

InnovaTV 301/ENGOT-cx12/GOG-3057: A global, randomized, open-label, phase III study of tisotumab vedotin vs investigator's choice of chemotherapy in 2L or 3L recurrent or metastati... von Fujiwara, K, Slomovitz, B.M, Gonzalez Martin, A, Kalbacher, E, Bagameri, A, Ghamande, S, Lee, J.-Y, Banerjee, S, Maluf, F.C, Lorusso, D, Yonemori, K, van Nieuwenhuysen, E, Manso Sanchez, L.M, Woelber, L, Westermann, A.M, Covens, A, Whalley, E, Teng, M.S.L, Soumaoro, I, Vergote, I.B

Volltext

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial von Naumann, RW, Hollebecque, A, Meyer, T, Devlin, M-J, Oaknin, A, Kerger, J, López-Picazo, JM, Machiels, J-P, Delord, J-P, Evans, TRJ, Boni, V, Calvo, E, Topalian, SL, Chen, T, Soumaoro, I, Li, B, Gu, J, Zwirtes, R, Moore, KN

Volltext bestellen

Adaptations of market garden producers to climate change in southern Mali von Soumaoro, Tiémoko

Volltext

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial von Naumann, R Wendel, Hollebecque, Antoine, Meyer, Tim, Devlin, Michael-John, Oaknin, Ana, Kerger, Joseph, López-Picazo, Jose M, Machiels, Jean-Pascal, Delord, Jean-Pierre, Evans, Thomas R J, Boni, Valentina, Calvo, Emiliano, Topalian, Suzanne L, Chen, Tian, Soumaoro, Ibrahima, Li, Bin, Gu, Junchen, Zwirtes, Ricardo, Moore, Kathleen N

Volltext

Cyclooxygenase-2 expression: A significant prognostic indicator for patients with colorectal cancer von TOGBA SOUMAORO, Labile, UETAKE, Hiroyuki, HIGUCHI, Tetsuro, TAKAGI, Yoko, ENOMOTO, Masayuki, SUGIHARA, Kenichi

Volltext

Anxiety and depression among HIV patients of the infectious disease department of Conakry University Hospital in 2018 von Camara, A, Sow, M S, Touré, A, Sako, F B, Camara, I, Soumaoro, K, Delamou, A, Doukouré, M

Volltext

Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study von Yonemori, Kan, Kuboki, Yasutoshi, Hasegawa, Kosei, Iwata, Takashi, Kato, Hidenori, Takehara, Kazuhiro, Hirashima, Yasuyuki, Kato, Hisamori, Passey, Chaitali, Buchbjerg, Jeppe Klint, Harris, Jeffrey R., Andreassen, Camilla Mondrup, Nicacio, Leonardo, Soumaoro, Ibrahima, Fujiwara, Keiichi

Volltext

Exposure-safety and exposure-efficacy analyses for tisotumab vedotin for patients with locally advanced or metastatic solid tumors von Passey, Chaitali, Voellinger, Jenna, Gibiansky, Leonid, Gunawan, Rudy, Nicacio, Leonardo, Soumaoro, Ibrahima, Hanley, William D, Winter, Helen, Gupta, Manish

Volltext

Progress towards elimination of onchocerciasis transmission in Mali: A "pre-stop MDA" survey in 18 transmission zones von Dolo, Housseini, Coulibaly, Michel Emmanuel, Sow, Moussa, Coulibaly, Yaya Ibrahim, Doumbia, Mama, Sangare, Moussa, Sanogo, Abdoul, Dembele, Benoit, Guindo, Boubacar, Coulibaly, Mamadou, Keita, Modibo, Soumaoro, Lamine, Diarra, Dansine, Dicko, Boubacar, Hamill, Louise, Doumbia, Seydou, Sangho, Hamadoun, Sangare, Yacouba, Zhang, Yaobi, Tallant, Jamie, Yaro, Alpha Seydou, Mackenzie, Charles, Nutman, Thomas B, Boakye, Daniel

Volltext